Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Lopes

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Leukemia|December 17, 2025
The pathogenesis of therapy-related myeloid neoplasms from TP53-mutant clonal hematopoiesisJonas Fullin, Ebru Topçu, Karolina A Zielińska, et al.
Nature Structural & Molecular Biology|February 12, 2013
Human RECQ1 promotes restart of replication forks reversed by DNA topoisomerase I inhibitionMatteo Berti, Arnab Ray Chaudhuri, Saravanabhavan Thangavel, et al.
Blood|January 6, 2026
Bone marrow failure, somatic rescue by p53 inactivation, and enhanced leukemogenesis in germline ERCC6L2 diseaseRoman Schimmer, Nancy Klemm, Jonas Fullin, et al.
Oncogene|December 17, 2025
MDC1 counteracts replication fork reversal and mediates chemosensitivity in BRCA1/2-deficient tumorsHülya Dogan, Martin Liptay, Joana S Barbosa, et al.
Nature Communications|October 12, 2023
Proteogenetic drug response profiling elucidates targetable vulnerabilities of myelofibrosisMattheus H E Wildschut, Julien Mena, Cyril Dördelmann, et al.
Nature Cell Biology|June 21, 2016
Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensingPanagiotis Galanos, Konstantinos Vougas, David Walter, et al.
Nature Communications|May 24, 2024
H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumoursDiego Dibitetto, Martin Liptay, Francesca Vivalda, et al.
Cancer Cell|June 13, 2018
Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic LethalityEwa Gogola, Alexandra A Duarte, Julian R de Ruiter, et al.
Cancer Cell|June 12, 2019
Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic LethalityEwa Gogola, Alexandra A Duarte, Julian R de Ruiter, et al.
Cancer Cell|September 13, 2017
A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer DevelopmentYannick Boege, Mohsen Malehmir, Marc E Healy, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Leukemia|December 17, 2025
The pathogenesis of therapy-related myeloid neoplasms from TP53-mutant clonal hematopoiesisJonas Fullin, Ebru Topçu, Karolina A Zielińska, et al.
Nature Structural & Molecular Biology|February 12, 2013
Human RECQ1 promotes restart of replication forks reversed by DNA topoisomerase I inhibitionMatteo Berti, Arnab Ray Chaudhuri, Saravanabhavan Thangavel, et al.
Blood|January 6, 2026
Bone marrow failure, somatic rescue by p53 inactivation, and enhanced leukemogenesis in germline ERCC6L2 diseaseRoman Schimmer, Nancy Klemm, Jonas Fullin, et al.
Oncogene|December 17, 2025
MDC1 counteracts replication fork reversal and mediates chemosensitivity in BRCA1/2-deficient tumorsHülya Dogan, Martin Liptay, Joana S Barbosa, et al.
Nature Communications|October 12, 2023
Proteogenetic drug response profiling elucidates targetable vulnerabilities of myelofibrosisMattheus H E Wildschut, Julien Mena, Cyril Dördelmann, et al.
Nature Cell Biology|June 21, 2016
Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensingPanagiotis Galanos, Konstantinos Vougas, David Walter, et al.
Nature Communications|May 24, 2024
H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumoursDiego Dibitetto, Martin Liptay, Francesca Vivalda, et al.
Cancer Cell|June 13, 2018
Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic LethalityEwa Gogola, Alexandra A Duarte, Julian R de Ruiter, et al.
Cancer Cell|June 12, 2019
Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic LethalityEwa Gogola, Alexandra A Duarte, Julian R de Ruiter, et al.
Cancer Cell|September 13, 2017
A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer DevelopmentYannick Boege, Mohsen Malehmir, Marc E Healy, et al.
Pageof 8